Approval · Notice of Compliance 26151 · 2021
ATRIDOX: Notice of Compliance 26151
Issued June 28, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26151
- Date
- June 28, 2021
- Company
- Den-Mat Holdings, LLCLompoc, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- A change in manufacturing site, a change in packaging supplier for the syringes, a label update to meet Plain Language Labelling (PLL) requirements, and a change in the delivery system brand name in the Product Monograph(PM) and labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATRIDOX | Not yet assigned | — |
Medicinal ingredients
- DOXYCYCLINE HYCLATE 8.8 PER